Sterility testing is crucial in the life sciences industry. It provides direct evidence that products intended to be sterile like injectable drugs, implantable devices, cell therapies, and media used in manufacturing are free from viable microorganisms that could harm patients or compromise processes. Contamination can cause serious infections, trigger immune reactions, or ruin high-value batches. Regulators require sterile process validation and use of compendial sterility tests as part of initial process setup, batch release and ongoing process verification. Product sterility testing serves as a final check on the effectiveness of all upstream bioburden controls.
No, other products such as ophthalmic formulations can also require sterility testing. Producers may consider a sterile specification for a finished good, even when not formally required, to support product stability.
Yes, we follow USP <71> and Ph. Eur. (2.6.1)
Absolutely! We support sterile manufacturers with Environmental Bioburden Monitoring, Facility Water Testing, and other tools to help them meet their sterility specifications.
Standard compendial sterility testing requires a 14-day incubation period to allow detection of slow-growing microorganisms. Results are reported after completion of the incubation and review of test data.
Sterility testing confirms that a product intended to be sterile is free from viable microorganisms. It is a regulatory requirement for many pharmaceutical products, biologics, medical devices, and cell-based therapies to help ensure patient safety and product quality.
